SuperworthOscar Health EPS OSCR
Diluted earnings per share by quarter and over the last twelve months, from 2020.
- Last 12 months, to Jun 30, 2026
- $1.39
- Latest quarter, Q2 FY26
- $1.10
- Fiscal year 2025
- −$1.75
Oscar Health's earnings per share was $1.39 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was $1.10.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$1.75 | n/a |
| FY2024 | −$0.02 | n/a |
| FY2023 | −$1.20 | n/a |
| FY2022 | −$2.85 | n/a |
| FY2021 | −$3.32 | n/a |
| FY2020 | −$14.03 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $1.10 | n/a | $1.39 | |
| Q1 FY26 | $2.07 | +125% | −$0.60 | |
| Q4 FY25 | −$1.25 | n/a | −$1.75 | |
| Q3 FY25 | −$0.53 | n/a | −$1.12 | |
| Q2 FY25 | −$0.89 | −545% | −$0.81 | |
| Q1 FY25 | $0.92 | +48% | $0.28 | |
| Q4 FY24 | −$0.62 | n/a | −$0.02 | |
| Q3 FY24 | −$0.22 | n/a | −$0.06 | |
| Q2 FY24 | $0.20 | n/a | −$0.13 | |
| Q1 FY24 | $0.62 | n/a | −$0.40 | |
| Q4 FY23 | −$0.66 | n/a | −$1.20 | |
| Q3 FY23 | −$0.29 | n/a | −$1.59 |
Against its peers
Companies in Medical - Healthcare Plans nearest Oscar Health's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| OSCROscar Health | $1.39 | |
| CNCCentene | −$10.44 | −358% a year |
| HUMHumana | $10.57 | −19% a year |
| ALHCAlignment Healthcare | $0.19 | |
| TRUPTrupanion | $0.53 | +104% a year |
| CICigna | $24.17 | +32% a year |
| ELVElevance Health | $22.50 | −4% a year |
| Peer median | $5.55 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Oscar Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.